Bala Venkataraman

Bala Venkataraman is an experienced operating executive in the specialty pharmaceutical industry. Most recently, Bala was Co-Founder and Executive Chairman of Vidara Therapeutics until its sale to Horizon Pharma in September 2014. Prior to founding Vidara Therapeutics, Bala was the Co-Founder and CEO of Alaven Pharmaceutical from 2003 until its sale to Meda Pharma in October 2010. Bala also served as Chief Operating Officer, Chief Financial Officer and Vice President of Business Development, Strategic Planning and Operations at First Horizon Pharmaceutical (now Shionogi Pharma). Bala has authored several papers in research publications related to medicinal chemistry and holds numerous drug and formulation patents.

Bala holds an MS in Chemistry from Case Western University and an MBA from the Wharton School of the University of Pennsylvania.